Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable performance history.
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox is attractively valued after underperformance, offering a 5% dividend yield and normalization post-cyber attack and ERP disruptions. The recent Purell (GOJO) acquisition is set to be accretive to EBITDA and EPS by FY27, supporting top-line growth above the company's long-term algorithm. CLX trades at 14.5x FY27 EPS, with double-digit earnings growth and room for multiple expansion relative to peers, setting up 20% upside potential.
CLX heads into Q3 earnings with rising costs, soft demand and margin pressure, even as its IGNITE strategy and cost savings initiatives aim to stabilize performance.
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (NYSE:CLX) stock just picked up one of Wall Street's most bearish signals.
A year ago, we identified three Dividend Aristocrats trading at compelling discounts to fair value.
The Clorox Company is seeing lower profits and sales volumes, but I see these as transitory setbacks. Shares in the cleaning products maker are trading near their 52-week lows, and I believe this presents an attractive opportunity for upside. The stock comes attached with what I view as an attractive dividend yield.
CLX drives growth with innovation and digital upgrades, positioning its international expansion as a key long-term lever.
CLX navigates ERP disruption and macro headwinds while advancing digital transformation to drive efficiency and margin gains.
The Clorox Company (CLX) Presents at Citi's 2026 Global Consumer & Retail Conference 2026 Transcript
CLX's international push gains traction: segment sales rose 7% to $294M and EBIT jumped 48%, highlighting emerging markets as a key growth driver.